Fidelity Investments’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-35,061
| Closed | -$55.7K | – | 5747 |
|
|
2024
Q1 | $55.7K | Sell |
35,061
-32,430
| -48% | -$51.6K | ﹤0.01% | 3527 |
|
|
2023
Q4 | $58K | Buy |
67,491
+5,778
| +9% | +$4.96K | ﹤0.01% | 3454 |
|
|
2023
Q3 | $66K | Buy |
61,713
+13,565
| +28% | +$14.5K | ﹤0.01% | 3260 |
|
|
2023
Q2 | $125K | Buy |
48,148
+1,142
| +2% | +$2.96K | ﹤0.01% | 3089 |
|
|
2023
Q1 | $192K | Buy |
47,006
+611
| +1% | +$2.49K | ﹤0.01% | 2997 |
|
|
2022
Q4 | $233K | Sell |
46,395
-4,277,806
| -99% | -$21.5M | ﹤0.01% | 2961 |
|
|
2022
Q3 | $56.6M | Buy |
4,324,201
+2,263,668
| +110% | +$29.6M | 0.01% | 1201 |
|
|
2022
Q2 | $26.4M | Buy |
2,060,533
+787,347
| +62% | +$10.1M | ﹤0.01% | 1540 |
|
|
2022
Q1 | $19.4M | Sell |
1,273,186
-27,952
| -2% | -$426K | ﹤0.01% | 1792 |
|
|
2021
Q4 | $23M | Sell |
1,301,138
-6,799
| -0.5% | -$120K | ﹤0.01% | 1756 |
|
|
2021
Q3 | $27.5M | Buy |
+1,307,937
| New | +$27.5M | ﹤0.01% | 1684 |
|
|
2019
Q4 | – | Sell |
-288,200
| Closed | -$3.99M | – | 4356 |
|
|
2019
Q3 | $3.99M | Hold |
288,200
| – | – | ﹤0.01% | 2113 |
|
|
2019
Q2 | $4.22M | Buy |
+288,200
| New | +$4.22M | ﹤0.01% | 2143 |
|